BLRX · BioLineRx Ltd.
$2.71
-0.05 (-1.81%)
At close · Aug 17
Market Cap
$12.42M
Shares
4.50M
BioLineRx Ltd. Earnings Call Transcripts
Every quarterly earnings call for BioLineRx Ltd. (BLRX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY25 · Q3
2025-09-30
BioLineRx Ltd. Q3 FY2025 Earnings Call
Confident tone
GLIX1 joint venture for glioblastoma
APHEXDA out-licensing / Ayrmid
Pancreatic cancer (PDAC) / CheMo4METPANC trial
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
BioLineRx Ltd. Q2 FY2025 Earnings Call
Confident tone
Pancreatic cancer (PDAC) CheMo4METPANC trial
Motixafortide / APHEXDA commercial partnership with Ayrmid
Pipeline expansion / in-licensing
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
BioLineRx Ltd. Q1 FY2025 Earnings Call
Positive tone
APHEXDA out-licensing and commercial performance
Gloria Bio licensing agreement
Pancreatic cancer (PDAC) CheMo4METPANC trial
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
BioLineRx Ltd. Q3 FY2024 Earnings Call
Confident tone
Ayrmid/Gamida Cell licensing transaction
PDAC / pancreatic cancer program
Cost reduction and cash runway
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
BioLineRx Ltd. Q2 FY2024 Earnings Call
Confident tone
APHEXDA launch and formulary adoption
Financial performance and revenue
Sickle cell disease and gene therapy studies
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
BioLineRx Ltd. Q1 FY2024 Earnings Call
Confident tone
APHEXDA Commercial Launch
Pancreatic Cancer Program (CheMo4METPANC)
Gloria Biosciences Asia Partnership
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
BioLineRx Ltd. Q4 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
BioLineRx Ltd. Q3 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
BioLineRx Ltd. Q2 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
BioLineRx Ltd. Q1 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
BioLineRx Ltd. Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
BioLineRx Ltd. Q3 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
BioLineRx Ltd. Q2 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
BioLineRx Ltd. Q1 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
BioLineRx Ltd. Q4 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-09-30
BioLineRx Ltd. Q3 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
BioLineRx Ltd. Q2 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
BioLineRx Ltd. Q1 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–18 of 18 earnings calls
Key facts
CIK
1498403
CUSIP
09071M304
13F (30d)
14 filings
14 filers
Visit website
Investor relations